img

Global Purpura Therapy Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Purpura Therapy Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Purpura is one of the common hemorrhagic diseases in children, which is characterized by blood spillage under skin and mucous membrane, petechiae and pressure stasis
Purpura Therapy Drugs report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Purpura Therapy Drugs market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital Use and Clinic Use are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Purpura Therapy Drugs industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Purpura Therapy Drugs key manufacturers include Bristol-Myers Squibb Company, Pfizer Inc, GlaxoSmithKline Plc, Novartis AG, Hovione, Sanofi Winthrop Industrie S.A., Hoffman-L Roche, Amgen Inc and Grifols Biologicals Inc, etc. Bristol-Myers Squibb Company, Pfizer Inc, GlaxoSmithKline Plc are top 3 players and held % sales share in total in 2022.
Purpura Therapy Drugs can be divided into Allergic Purpura and Thrombocytopenic Purpura, etc. Allergic Purpura is the mainstream product in the market, accounting for % sales share globally in 2022.
Purpura Therapy Drugs is widely used in various fields, such as Hospital Use, Clinic Use, Household and Other, etc. Hospital Use provides greatest supports to the Purpura Therapy Drugs industry development. In 2022, global % sales of Purpura Therapy Drugs went into Hospital Use filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Purpura Therapy Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Bristol-Myers Squibb Company
Pfizer Inc
GlaxoSmithKline Plc
Novartis AG
Hovione
Sanofi Winthrop Industrie S.A.
Hoffman-L Roche
Amgen Inc
Grifols Biologicals Inc
Ablynx NV
Biogen Inc
KM Biologics
Lee's Pharmaceutical Holdings Ltd
Omeros Corp
Takeda
Roch
Segment by Type
Allergic Purpura
Thrombocytopenic Purpura

Segment by Application


Hospital Use
Clinic Use
Household
Other

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Purpura Therapy Drugs market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Purpura Therapy Drugs, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Purpura Therapy Drugs industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Purpura Therapy Drugs in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Purpura Therapy Drugs introduction, etc. Purpura Therapy Drugs Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Purpura Therapy Drugs market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Purpura Therapy Drugs Market Overview
1.1 Purpura Therapy Drugs Product Overview
1.2 Purpura Therapy Drugs Market Segment by Type
1.2.1 Allergic Purpura
1.2.2 Thrombocytopenic Purpura
1.3 Global Purpura Therapy Drugs Market Size by Type
1.3.1 Global Purpura Therapy Drugs Market Size Overview by Type (2018-2034)
1.3.2 Global Purpura Therapy Drugs Historic Market Size Review by Type (2018-2024)
1.3.3 Global Purpura Therapy Drugs Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Purpura Therapy Drugs Sales Breakdown by Type (2018-2024)
1.4.2 Europe Purpura Therapy Drugs Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Purpura Therapy Drugs Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Purpura Therapy Drugs Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Purpura Therapy Drugs Sales Breakdown by Type (2018-2024)
2 Global Purpura Therapy Drugs Market Competition by Company
2.1 Global Top Players by Purpura Therapy Drugs Sales (2018-2024)
2.2 Global Top Players by Purpura Therapy Drugs Revenue (2018-2024)
2.3 Global Top Players by Purpura Therapy Drugs Price (2018-2024)
2.4 Global Top Manufacturers Purpura Therapy Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Purpura Therapy Drugs Market Competitive Situation and Trends
2.5.1 Purpura Therapy Drugs Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Purpura Therapy Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Purpura Therapy Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Purpura Therapy Drugs Market
2.8 Key Manufacturers Purpura Therapy Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Purpura Therapy Drugs Status and Outlook by Region
3.1 Global Purpura Therapy Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Purpura Therapy Drugs Historic Market Size by Region
3.2.1 Global Purpura Therapy Drugs Sales in Volume by Region (2018-2024)
3.2.2 Global Purpura Therapy Drugs Sales in Value by Region (2018-2024)
3.2.3 Global Purpura Therapy Drugs Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Purpura Therapy Drugs Forecasted Market Size by Region
3.3.1 Global Purpura Therapy Drugs Sales in Volume by Region (2024-2034)
3.3.2 Global Purpura Therapy Drugs Sales in Value by Region (2024-2034)
3.3.3 Global Purpura Therapy Drugs Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Purpura Therapy Drugs by Application
4.1 Purpura Therapy Drugs Market Segment by Application
4.1.1 Hospital Use
4.1.2 Clinic Use
4.1.3 Household
4.1.4 Other
4.2 Global Purpura Therapy Drugs Market Size by Application
4.2.1 Global Purpura Therapy Drugs Market Size Overview by Application (2018-2034)
4.2.2 Global Purpura Therapy Drugs Historic Market Size Review by Application (2018-2024)
4.2.3 Global Purpura Therapy Drugs Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Purpura Therapy Drugs Sales Breakdown by Application (2018-2024)
4.3.2 Europe Purpura Therapy Drugs Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Purpura Therapy Drugs Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Purpura Therapy Drugs Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Purpura Therapy Drugs Sales Breakdown by Application (2018-2024)
5 North America Purpura Therapy Drugs by Country
5.1 North America Purpura Therapy Drugs Historic Market Size by Country
5.1.1 North America Purpura Therapy Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Purpura Therapy Drugs Sales in Volume by Country (2018-2024)
5.1.3 North America Purpura Therapy Drugs Sales in Value by Country (2018-2024)
5.2 North America Purpura Therapy Drugs Forecasted Market Size by Country
5.2.1 North America Purpura Therapy Drugs Sales in Volume by Country (2024-2034)
5.2.2 North America Purpura Therapy Drugs Sales in Value by Country (2024-2034)
6 Europe Purpura Therapy Drugs by Country
6.1 Europe Purpura Therapy Drugs Historic Market Size by Country
6.1.1 Europe Purpura Therapy Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Purpura Therapy Drugs Sales in Volume by Country (2018-2024)
6.1.3 Europe Purpura Therapy Drugs Sales in Value by Country (2018-2024)
6.2 Europe Purpura Therapy Drugs Forecasted Market Size by Country
6.2.1 Europe Purpura Therapy Drugs Sales in Volume by Country (2024-2034)
6.2.2 Europe Purpura Therapy Drugs Sales in Value by Country (2024-2034)
7 Asia-Pacific Purpura Therapy Drugs by Region
7.1 Asia-Pacific Purpura Therapy Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Purpura Therapy Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Purpura Therapy Drugs Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Purpura Therapy Drugs Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Purpura Therapy Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Purpura Therapy Drugs Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Purpura Therapy Drugs Sales in Value by Region (2024-2034)
8 Latin America Purpura Therapy Drugs by Country
8.1 Latin America Purpura Therapy Drugs Historic Market Size by Country
8.1.1 Latin America Purpura Therapy Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Purpura Therapy Drugs Sales in Volume by Country (2018-2024)
8.1.3 Latin America Purpura Therapy Drugs Sales in Value by Country (2018-2024)
8.2 Latin America Purpura Therapy Drugs Forecasted Market Size by Country
8.2.1 Latin America Purpura Therapy Drugs Sales in Volume by Country (2024-2034)
8.2.2 Latin America Purpura Therapy Drugs Sales in Value by Country (2024-2034)
9 Middle East and Africa Purpura Therapy Drugs by Country
9.1 Middle East and Africa Purpura Therapy Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Purpura Therapy Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Purpura Therapy Drugs Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Purpura Therapy Drugs Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Purpura Therapy Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Purpura Therapy Drugs Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Purpura Therapy Drugs Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Bristol-Myers Squibb Company
10.1.1 Bristol-Myers Squibb Company Company Information
10.1.2 Bristol-Myers Squibb Company Introduction and Business Overview
10.1.3 Bristol-Myers Squibb Company Purpura Therapy Drugs Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Bristol-Myers Squibb Company Purpura Therapy Drugs Products Offered
10.1.5 Bristol-Myers Squibb Company Recent Development
10.2 Pfizer Inc
10.2.1 Pfizer Inc Company Information
10.2.2 Pfizer Inc Introduction and Business Overview
10.2.3 Pfizer Inc Purpura Therapy Drugs Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Pfizer Inc Purpura Therapy Drugs Products Offered
10.2.5 Pfizer Inc Recent Development
10.3 GlaxoSmithKline Plc
10.3.1 GlaxoSmithKline Plc Company Information
10.3.2 GlaxoSmithKline Plc Introduction and Business Overview
10.3.3 GlaxoSmithKline Plc Purpura Therapy Drugs Sales, Revenue and Gross Margin (2018-2024)
10.3.4 GlaxoSmithKline Plc Purpura Therapy Drugs Products Offered
10.3.5 GlaxoSmithKline Plc Recent Development
10.4 Novartis AG
10.4.1 Novartis AG Company Information
10.4.2 Novartis AG Introduction and Business Overview
10.4.3 Novartis AG Purpura Therapy Drugs Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Novartis AG Purpura Therapy Drugs Products Offered
10.4.5 Novartis AG Recent Development
10.5 Hovione
10.5.1 Hovione Company Information
10.5.2 Hovione Introduction and Business Overview
10.5.3 Hovione Purpura Therapy Drugs Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Hovione Purpura Therapy Drugs Products Offered
10.5.5 Hovione Recent Development
10.6 Sanofi Winthrop Industrie S.A.
10.6.1 Sanofi Winthrop Industrie S.A. Company Information
10.6.2 Sanofi Winthrop Industrie S.A. Introduction and Business Overview
10.6.3 Sanofi Winthrop Industrie S.A. Purpura Therapy Drugs Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Sanofi Winthrop Industrie S.A. Purpura Therapy Drugs Products Offered
10.6.5 Sanofi Winthrop Industrie S.A. Recent Development
10.7 Hoffman-L Roche
10.7.1 Hoffman-L Roche Company Information
10.7.2 Hoffman-L Roche Introduction and Business Overview
10.7.3 Hoffman-L Roche Purpura Therapy Drugs Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Hoffman-L Roche Purpura Therapy Drugs Products Offered
10.7.5 Hoffman-L Roche Recent Development
10.8 Amgen Inc
10.8.1 Amgen Inc Company Information
10.8.2 Amgen Inc Introduction and Business Overview
10.8.3 Amgen Inc Purpura Therapy Drugs Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Amgen Inc Purpura Therapy Drugs Products Offered
10.8.5 Amgen Inc Recent Development
10.9 Grifols Biologicals Inc
10.9.1 Grifols Biologicals Inc Company Information
10.9.2 Grifols Biologicals Inc Introduction and Business Overview
10.9.3 Grifols Biologicals Inc Purpura Therapy Drugs Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Grifols Biologicals Inc Purpura Therapy Drugs Products Offered
10.9.5 Grifols Biologicals Inc Recent Development
10.10 Ablynx NV
10.10.1 Ablynx NV Company Information
10.10.2 Ablynx NV Introduction and Business Overview
10.10.3 Ablynx NV Purpura Therapy Drugs Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Ablynx NV Purpura Therapy Drugs Products Offered
10.10.5 Ablynx NV Recent Development
10.11 Biogen Inc
10.11.1 Biogen Inc Company Information
10.11.2 Biogen Inc Introduction and Business Overview
10.11.3 Biogen Inc Purpura Therapy Drugs Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Biogen Inc Purpura Therapy Drugs Products Offered
10.11.5 Biogen Inc Recent Development
10.12 KM Biologics
10.12.1 KM Biologics Company Information
10.12.2 KM Biologics Introduction and Business Overview
10.12.3 KM Biologics Purpura Therapy Drugs Sales, Revenue and Gross Margin (2018-2024)
10.12.4 KM Biologics Purpura Therapy Drugs Products Offered
10.12.5 KM Biologics Recent Development
10.13 Lee's Pharmaceutical Holdings Ltd
10.13.1 Lee's Pharmaceutical Holdings Ltd Company Information
10.13.2 Lee's Pharmaceutical Holdings Ltd Introduction and Business Overview
10.13.3 Lee's Pharmaceutical Holdings Ltd Purpura Therapy Drugs Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Lee's Pharmaceutical Holdings Ltd Purpura Therapy Drugs Products Offered
10.13.5 Lee's Pharmaceutical Holdings Ltd Recent Development
10.14 Omeros Corp
10.14.1 Omeros Corp Company Information
10.14.2 Omeros Corp Introduction and Business Overview
10.14.3 Omeros Corp Purpura Therapy Drugs Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Omeros Corp Purpura Therapy Drugs Products Offered
10.14.5 Omeros Corp Recent Development
10.15 Takeda
10.15.1 Takeda Company Information
10.15.2 Takeda Introduction and Business Overview
10.15.3 Takeda Purpura Therapy Drugs Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Takeda Purpura Therapy Drugs Products Offered
10.15.5 Takeda Recent Development
10.16 Roch
10.16.1 Roch Company Information
10.16.2 Roch Introduction and Business Overview
10.16.3 Roch Purpura Therapy Drugs Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Roch Purpura Therapy Drugs Products Offered
10.16.5 Roch Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Purpura Therapy Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Purpura Therapy Drugs Industrial Chain Analysis
11.4 Purpura Therapy Drugs Market Dynamics
11.4.1 Purpura Therapy Drugs Industry Trends
11.4.2 Purpura Therapy Drugs Market Drivers
11.4.3 Purpura Therapy Drugs Market Challenges
11.4.4 Purpura Therapy Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Purpura Therapy Drugs Distributors
12.3 Purpura Therapy Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Allergic Purpura
Table 2. Major Company of Thrombocytopenic Purpura
Table 3. Global Purpura Therapy Drugs Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 4. Global Purpura Therapy Drugs Sales by Type (2018-2024) & (K Pcs)
Table 5. Global Purpura Therapy Drugs Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Purpura Therapy Drugs Sales by Type (2018-2024) & (US& Million)
Table 7. Global Purpura Therapy Drugs Market Share in Value by Type (2018-2024)
Table 8. Global Purpura Therapy Drugs Price by Type (2018-2024) & (USD/Pcs)
Table 9. Global Purpura Therapy Drugs Sales by Type (2024-2034) & (K Pcs)
Table 10. Global Purpura Therapy Drugs Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Purpura Therapy Drugs Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Purpura Therapy Drugs Sales Market Share in Value by Type (2024-2034)
Table 13. Global Purpura Therapy Drugs Price by Type (2024-2034) & (USD/Pcs)
Table 14. North America Purpura Therapy Drugs Sales by Type (2018-2024) & (K Pcs)
Table 15. North America Purpura Therapy Drugs Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Purpura Therapy Drugs Sales (K Pcs) by Type (2018-2024)
Table 17. Europe Purpura Therapy Drugs Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Purpura Therapy Drugs Sales (K Pcs) by Type (2018-2024)
Table 19. Asia-Pacific Purpura Therapy Drugs Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Purpura Therapy Drugs Sales (K Pcs) by Type (2018-2024)
Table 21. Latin America Purpura Therapy Drugs Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Purpura Therapy Drugs Sales (K Pcs) by Type (2018-2024)
Table 23. Middle East and Africa Purpura Therapy Drugs Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Purpura Therapy Drugs Sales by Company (2018-2024) & (K Pcs)
Table 25. Global Purpura Therapy Drugs Sales Share by Company (2018-2024)
Table 26. Global Purpura Therapy Drugs Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Purpura Therapy Drugs Revenue Share by Company (2018-2024)
Table 28. Global Market Purpura Therapy Drugs Price by Company (2018-2024) & (USD/Pcs)
Table 29. Global Purpura Therapy Drugs Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Purpura Therapy Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Purpura Therapy Drugs as of 2022)
Table 32. Date of Key Manufacturers Enter into Purpura Therapy Drugs Market
Table 33. Key Manufacturers Purpura Therapy Drugs Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Purpura Therapy Drugs Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 36. Global Purpura Therapy Drugs Sales by Region (2018-2024) & (K Pcs)
Table 37. Global Purpura Therapy Drugs Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Purpura Therapy Drugs Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Purpura Therapy Drugs Sales Market Share in Value by Region (2018-2024)
Table 40. Global Purpura Therapy Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 41. Global Purpura Therapy Drugs Sales by Region (2024-2034) & (K Pcs)
Table 42. Global Purpura Therapy Drugs Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Purpura Therapy Drugs Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Purpura Therapy Drugs Sales Market Share in Value by Region (2024-2034)
Table 45. Global Purpura Therapy Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 46. Global Purpura Therapy Drugs Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 47. Global Purpura Therapy Drugs Sales by Application (2018-2024) & (K Pcs)
Table 48. Global Purpura Therapy Drugs Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Purpura Therapy Drugs Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Purpura Therapy Drugs Sales Market Share in Value by Application (2018-2024)
Table 51. Global Purpura Therapy Drugs Price by Application (2018-2024) & (USD/Pcs)
Table 52. Global Purpura Therapy Drugs Sales by Application (2024-2034) & (K Pcs)
Table 53. Global Purpura Therapy Drugs Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Purpura Therapy Drugs Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Purpura Therapy Drugs Sales Market Share in Value by Application (2024-2034)
Table 56. Global Purpura Therapy Drugs Price by Application (2024-2034) & (USD/Pcs)
Table 57. North America Purpura Therapy Drugs Sales by Application (2018-2024) (K Pcs)
Table 58. North America Purpura Therapy Drugs Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Purpura Therapy Drugs Sales by Application (2018-2024) (K Pcs)
Table 60. Europe Purpura Therapy Drugs Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Purpura Therapy Drugs Sales by Application (2018-2024) (K Pcs)
Table 62. Asia-Pacific Purpura Therapy Drugs Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Purpura Therapy Drugs Sales by Application (2018-2024) (K Pcs)
Table 64. Latin America Purpura Therapy Drugs Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Purpura Therapy Drugs Sales by Application (2018-2024) (K Pcs)
Table 66. Middle East and Africa Purpura Therapy Drugs Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Purpura Therapy Drugs Sales by Country (2018-2024) & (K Pcs)
Table 68. North America Purpura Therapy Drugs Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Purpura Therapy Drugs Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Purpura Therapy Drugs Sales Market Share in Value by Country (2018-2024)
Table 71. North America Purpura Therapy Drugs Sales by Country (2024-2034) & (K Pcs)
Table 72. North America Purpura Therapy Drugs Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Purpura Therapy Drugs Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Purpura Therapy Drugs Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Purpura Therapy Drugs Sales by Country (2018-2024) & (K Pcs)
Table 76. Europe Purpura Therapy Drugs Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Purpura Therapy Drugs Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Purpura Therapy Drugs Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Purpura Therapy Drugs Sales by Country (2024-2034) & (K Pcs)
Table 80. Europe Purpura Therapy Drugs Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Purpura Therapy Drugs Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Purpura Therapy Drugs Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Purpura Therapy Drugs Sales by Region (2018-2024) & (K Pcs)
Table 84. Asia-Pacific Purpura Therapy Drugs Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Purpura Therapy Drugs Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Purpura Therapy Drugs Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Purpura Therapy Drugs Sales by Region (2024-2034) & (K Pcs)
Table 88. Asia-Pacific Purpura Therapy Drugs Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Purpura Therapy Drugs Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Purpura Therapy Drugs Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Purpura Therapy Drugs Sales by Country (2018-2024) & (K Pcs)
Table 92. Latin America Purpura Therapy Drugs Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Purpura Therapy Drugs Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Purpura Therapy Drugs Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Purpura Therapy Drugs Sales by Country (2024-2034) & (K Pcs)
Table 96. Latin America Purpura Therapy Drugs Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Purpura Therapy Drugs Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Purpura Therapy Drugs Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Purpura Therapy Drugs Sales by Country (2018-2024) & (K Pcs)
Table 100. Middle East and Africa Purpura Therapy Drugs Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Purpura Therapy Drugs Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Purpura Therapy Drugs Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Purpura Therapy Drugs Sales by Country (2024-2034) & (K Pcs)
Table 104. Middle East and Africa Purpura Therapy Drugs Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Purpura Therapy Drugs Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Purpura Therapy Drugs Sales Market Share in Value by Country (2024-2034)
Table 107. Bristol-Myers Squibb Company Company Information
Table 108. Bristol-Myers Squibb Company Introduction and Business Overview
Table 109. Bristol-Myers Squibb Company Purpura Therapy Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 110. Bristol-Myers Squibb Company Purpura Therapy Drugs Product
Table 111. Bristol-Myers Squibb Company Recent Development
Table 112. Pfizer Inc Company Information
Table 113. Pfizer Inc Introduction and Business Overview
Table 114. Pfizer Inc Purpura Therapy Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 115. Pfizer Inc Purpura Therapy Drugs Product
Table 116. Pfizer Inc Recent Development
Table 117. GlaxoSmithKline Plc Company Information
Table 118. GlaxoSmithKline Plc Introduction and Business Overview
Table 119. GlaxoSmithKline Plc Purpura Therapy Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 120. GlaxoSmithKline Plc Purpura Therapy Drugs Product
Table 121. GlaxoSmithKline Plc Recent Development
Table 122. Novartis AG Company Information
Table 123. Novartis AG Introduction and Business Overview
Table 124. Novartis AG Purpura Therapy Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 125. Novartis AG Purpura Therapy Drugs Product
Table 126. Novartis AG Recent Development
Table 127. Hovione Company Information
Table 128. Hovione Introduction and Business Overview
Table 129. Hovione Purpura Therapy Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 130. Hovione Purpura Therapy Drugs Product
Table 131. Hovione Recent Development
Table 132. Sanofi Winthrop Industrie S.A. Company Information
Table 133. Sanofi Winthrop Industrie S.A. Introduction and Business Overview
Table 134. Sanofi Winthrop Industrie S.A. Purpura Therapy Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 135. Sanofi Winthrop Industrie S.A. Purpura Therapy Drugs Product
Table 136. Sanofi Winthrop Industrie S.A. Recent Development
Table 137. Hoffman-L Roche Company Information
Table 138. Hoffman-L Roche Introduction and Business Overview
Table 139. Hoffman-L Roche Purpura Therapy Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 140. Hoffman-L Roche Purpura Therapy Drugs Product
Table 141. Hoffman-L Roche Recent Development
Table 142. Amgen Inc Company Information
Table 143. Amgen Inc Introduction and Business Overview
Table 144. Amgen Inc Purpura Therapy Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 145. Amgen Inc Purpura Therapy Drugs Product
Table 146. Amgen Inc Recent Development
Table 147. Grifols Biologicals Inc Company Information
Table 148. Grifols Biologicals Inc Introduction and Business Overview
Table 149. Grifols Biologicals Inc Purpura Therapy Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 150. Grifols Biologicals Inc Purpura Therapy Drugs Product
Table 151. Grifols Biologicals Inc Recent Development
Table 152. Ablynx NV Company Information
Table 153. Ablynx NV Introduction and Business Overview
Table 154. Ablynx NV Purpura Therapy Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 155. Ablynx NV Purpura Therapy Drugs Product
Table 156. Ablynx NV Recent Development
Table 157. Biogen Inc Company Information
Table 158. Biogen Inc Introduction and Business Overview
Table 159. Biogen Inc Purpura Therapy Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 160. Biogen Inc Purpura Therapy Drugs Product
Table 161. Biogen Inc Recent Development
Table 162. KM Biologics Company Information
Table 163. KM Biologics Introduction and Business Overview
Table 164. KM Biologics Purpura Therapy Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 165. KM Biologics Purpura Therapy Drugs Product
Table 166. KM Biologics Recent Development
Table 167. Lee's Pharmaceutical Holdings Ltd Company Information
Table 168. Lee's Pharmaceutical Holdings Ltd Introduction and Business Overview
Table 169. Lee's Pharmaceutical Holdings Ltd Purpura Therapy Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 170. Lee's Pharmaceutical Holdings Ltd Purpura Therapy Drugs Product
Table 171. Lee's Pharmaceutical Holdings Ltd Recent Development
Table 172. Omeros Corp Company Information
Table 173. Omeros Corp Introduction and Business Overview
Table 174. Omeros Corp Purpura Therapy Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 175. Omeros Corp Purpura Therapy Drugs Product
Table 176. Omeros Corp Recent Development
Table 177. Takeda Company Information
Table 178. Takeda Introduction and Business Overview
Table 179. Takeda Purpura Therapy Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 180. Takeda Purpura Therapy Drugs Product
Table 181. Takeda Recent Development
Table 182. Roch Company Information
Table 183. Roch Introduction and Business Overview
Table 184. Roch Purpura Therapy Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 185. Roch Purpura Therapy Drugs Product
Table 186. Roch Recent Development
Table 187. Key Raw Materials Lists
Table 188. Raw Materials Key Suppliers Lists
Table 189. Purpura Therapy Drugs Market Trends
Table 190. Purpura Therapy Drugs Market Drivers
Table 191. Purpura Therapy Drugs Market Challenges
Table 192. Purpura Therapy Drugs Market Restraints
Table 193. Purpura Therapy Drugs Distributors List
Table 194. Purpura Therapy Drugs Downstream Customers
Table 195. Research Programs/Design for This Report
Table 196. Key Data Information from Secondary Sources
Table 197. Key Data Information from Primary Sources
List of Figures
Figure 1. Purpura Therapy Drugs Product Picture
Figure 2. Global Purpura Therapy Drugs Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Purpura Therapy Drugs Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Purpura Therapy Drugs Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of Allergic Purpura
Figure 6. Global Allergic Purpura Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of Thrombocytopenic Purpura
Figure 8. Global Thrombocytopenic Purpura Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Global Purpura Therapy Drugs Sales by Type (2018-2034) & (US$ Million)
Figure 10. Global Purpura Therapy Drugs Sales Market Share by Type in 2022 & 2034
Figure 11. North America Purpura Therapy Drugs Sales Market Share in Volume by Type in 2022
Figure 12. North America Purpura Therapy Drugs Sales Market Share in Value by Type in 2022
Figure 13. Europe Purpura Therapy Drugs Sales Market Share in Volume by Type in 2022
Figure 14. Europe Purpura Therapy Drugs Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Purpura Therapy Drugs Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Purpura Therapy Drugs Sales Market Share in Value by Type in 2022
Figure 17. Latin America Purpura Therapy Drugs Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Purpura Therapy Drugs Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Purpura Therapy Drugs Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Purpura Therapy Drugs Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Purpura Therapy Drugs Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Purpura Therapy Drugs Revenue in 2022
Figure 23. Purpura Therapy Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Hospital Use
Figure 25. Global Hospital Use Sales YoY Growth (2018-2034) & (K Pcs)
Figure 26. Product Picture of Clinic Use
Figure 27. Global Clinic Use Sales YoY Growth (2018-2034) & (K Pcs)
Figure 28. Product Picture of Household
Figure 29. Global Household Sales YoY Growth (2018-2034) & (K Pcs)
Figure 30. Product Picture of Other
Figure 31. Global Other Sales YoY Growth (2018-2034) & (K Pcs)
Figure 32. Global Purpura Therapy Drugs Sales by Application (2018-2034) & (US$ Million)
Figure 33. Global Purpura Therapy Drugs Sales Market Share by Application in 2022 & 2034
Figure 34. North America Purpura Therapy Drugs Sales Market Share in Volume by Application in 2022
Figure 35. North America Purpura Therapy Drugs Sales Market Share in Value by Application in 2022
Figure 36. Europe Purpura Therapy Drugs Sales Market Share in Volume by Application in 2022
Figure 37. Europe Purpura Therapy Drugs Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Purpura Therapy Drugs Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Purpura Therapy Drugs Sales Market Share in Value by Application in 2022
Figure 40. Latin America Purpura Therapy Drugs Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Purpura Therapy Drugs Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Purpura Therapy Drugs Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Purpura Therapy Drugs Manufacturing Cost Structure
Figure 45. Purpura Therapy Drugs Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries